Clinical Trial Update: Therapeutic RSK1 Targeting in Myelofibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update focusing on a therapy targeting RSK1 for myelofibrosis, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• RSK1-targeting therapy

Snippet

Sponsor: Washington University School of Medicine | Conditions: Myelofibrosis | Phase 1 | Status: NOT_YET_RECRUITING